MMSI · Merit Medical Systems Inc
Market Cap
$5.35B
Shares
59.71M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$1.52B
+11.8%
FY2025
Net Income
$128.49M
+6.8%
FY2025
Gross Margin
48.7%
+1.3pp
FY2025
Operating Margin
12.19%
+0.7pp
FY2025
Diluted EPS
$2.13
+4.9%
FY2025
Operating Cash Flow
$297.37M
+34.7%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $1.63B – $1.64B | $1.58B | $1.52BG | $1.36B | $1.26B | $1.15B | $1.07B | $963.88M | $994.85M | $882.75M | $727.85M | $603.84M | — | — | — | — | $359.45M | $296.76M | $257.46M | |
| — | $797.09M | $777.64M | $713.18M | $673.49M | $631.88M | $589.42M | $562.7M | $562.49M | $487.98M | $401.6M | $338.81M | $306.37M | $284.47M | $254.68M | $212.3M | $193.98M | $168.26M | $148.66M | |
| — | $781.73M | $738.27M | $643.33M | $583.87M | $519.1M | $485.33M | $401.18M | $432.37M | $394.77M | $326.25M | $265.03M | $235.78M | $225.22M | $194.37M | $181.99M | $165.47M | $128.5M | $108.8M | |
| — | — | 48.7% | 47.43% | 46.44% | 45.1% | 45.16% | 41.62% | 43.46% | 44.72% | 44.82% | 43.89% | — | — | — | — | 46.03% | 43.3% | 42.26% | |
| — | $98.51M | $97.35M | $87.47M | $82.73M | $75.51M | $71.25M | $57.54M | $65.62M | $59.53M | $51.4M | $45.23M | $40.81M | $36.63M | $33.89M | $27.8M | $21.94M | $15.34M | $11.17M | |
| — | $482.07M | $455.21M | $399.73M | $373.68M | $342.53M | $335.69M | $297.72M | $327.27M | $276.02M | $229.13M | $184.4M | $156.35M | $147.89M | $128.64M | $122.11M | $104.5M | $87.62M | $64.79M | |
| — | $85.5M | $85.1M | $65.6M | $56.1M | $48.4M | $49.6M | $58.6M | $60.7M | $41.2M | $26.8M | $19.3M | $14.8M | $14.9M | $14.2M | $7.5M | $6M | $3.5M | — | |
| — | $124.37M | $123.17M | $102.71M | $89.99M | $81.8M | $84.07M | $94.07M | $92.1M | $69.55M | $53.58M | $43.76M | $37.43M | $35.93M | $32.54M | $22.53M | $19.19M | $14.86M | $12.27M | |
| — | — | $5.9M | $3.1M | $2.7M | $7.2M | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | $580.36M | $553.55M | $487.64M | $459.93M | $431.54M | $424.42M | $402.74M | $416.93M | $336.15M | $293.18M | $230.15M | $198.24M | $185.06M | $166.52M | $152.35M | $132.28M | $111.29M | $75.96M | |
| — | $201.37M | $184.72M | $155.69M | $123.94M | $87.56M | $60.92M | -$1.56M | $15.43M | $58.62M | $33.07M | $34.88M | $37.54M | $40.17M | $27.84M | $29.64M | $33.19M | $17.2M | $32.85M | |
| — | — | 12.19% | 11.48% | 9.86% | 7.61% | 5.67% | -0.16% | 1.55% | 6.64% | 4.54% | 5.78% | — | — | — | — | 9.23% | 5.8% | 12.76% | |
| — | $325.74M | $307.89M | $258.4M | $213.93M | $169.37M | $144.98M | $92.51M | $107.53M | $128.16M | $86.65M | $78.63M | $74.97M | $76.1M | $60.39M | $52.18M | $52.38M | $32.06M | $45.12M | |
| — | $31.76M | $26.46M | $31.22M | $15.51M | $6.34M | $5.26M | $9.99M | $12.41M | $10.36M | $7.74M | $8.8M | $6.23M | $8.83M | $8.04M | $604K | $789K | $596K | $28K | |
| — | $1.38M | — | — | — | — | — | — | — | $1.2M | $381K | $81K | $272K | $217K | $255K | $226K | $129K | $34K | $178K | |
| — | -$6.91M | -$13.78M | -$5.7M | -$11.86M | -$4.93M | -$7M | -$11.67M | -$13.24M | -$9.1M | $2.81M | -$9.49M | -$6.34M | -$8.59M | -$8.01M | -$2.02M | -$315K | -$416K | $247K | |
| — | $194.46M | $170.94M | $149.99M | $112.09M | $82.63M | $53.92M | -$13.23M | $2.19M | $49.52M | $35.88M | $25.39M | $31.2M | $31.57M | $19.84M | $27.62M | $32.88M | $16.79M | $33.09M | |
| — | $48.9M | $42.45M | $29.64M | $17.68M | $8.11M | $5.46M | -$3.39M | -$3.26M | $7.5M | $8.36M | $5.27M | $7.4M | $8.6M | $3.27M | $7.91M | $9.83M | $4.33M | $10.56M | |
| — | $145.56M | $128.49M | $120.36M | $94.41M | $74.52M | $48.45M | -$9.84M | $5.45M | $42.02M | $27.52M | $20.12M | $23.8M | $22.97M | $16.57M | $19.71M | $23.04M | $12.46M | $22.53M | |
| — | — | 8.48% | 8.87% | 7.51% | 6.47% | 4.51% | -1.02% | 0.55% | 4.76% | 3.78% | 3.33% | — | — | — | — | 6.41% | 4.2% | 8.75% | |
| — | $38.86M | — | — | — | — | — | — | — | $42.02M | $27.52M | $20.12M | $23.8M | $22.97M | $16.57M | $19.71M | $23.04M | $12.46M | — | |
| USD/shares | — | $2.45 | $2.17 | $2.07 | $1.64 | $1.31 | $0.86 | -$0.18 | $0.10 | $0.80 | $0.56 | $0.45 | $0.54 | $0.53 | $0.39 | $0.47 | $0.59 | $0.35 | $0.64 |
| USD/shares | $4.25 – $4.35* | $2.43 | $2.13 | $2.03G | $1.62G | $1.29G | $0.84 | -$0.18 | $0.10 | $0.78 | $0.55 | $0.45 | $0.53 | $0.53 | $0.39 | $0.46 | $0.58 | $0.35 | $0.63 |
| shares | — | — | 59.16M | 58.22M | 57.59M | 56.81M | 56.15M | 55.43M | 55.08M | 52.27M | 48.81M | 44.41M | 44.04M | 43.14M | 42.61M | 42.18M | 39.09M | 35.29M | 35.01M |
| shares | — | — | 60.46M | 59.37M | 58.36M | 57.67M | 57.36M | 55.43M | 56.24M | 53.93M | 50.1M | 44.86M | 44.51M | 43.41M | 42.88M | 42.61M | 39.73M | 35.98M | 35.76M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2009–FY2011: $2.47M in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
3.57×
Peer median 3.11×
EV/EBIT
27.98×
Peer median 33.60×
P/E (TTM)
36.85×
Peer median 37.58×
Peer medians compare against the 25 similar-size Medical Instruments & Supplies companies (of 45 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cardiovascular Segment | $1,443,042,000 | $1,301,744,000 | $1,220,560,000 | $1,118,224,000 | $1,043,227,000 | $934,202,000 | $960,981,000 | $849,477,000 |
| Endoscopy Segment | $72,864,000 | $54,770,000 | $36,806,000 | $32,757,000 | $31,524,000 | $29,673,000 | $33,871,000 | $33,276,000 |
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| United States | $909,466,000 | $800,780,000 | $726,989,000 | $650,559,000 | $608,878,000 | $550,061,000 | $575,711,000 | $496,413,000 |
| Non Us | $606,440,000 | $555,734,000 | $530,377,000 | $500,422,000 | $465,873,000 | $413,814,000 | $419,141,000 | $386,340,000 |
| China | — | — | — | $149,300,000 | $138,200,000 | $113,200,000 | $113,300,000 | $92,700,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Peripheral Intervention | $579,840,000 | $532,770,000 | $483,265,000 | $439,810,000 | $405,116,000 | $341,568,000 | $350,936,000 | $276,113,000 |
| Cardiac Intervention | $448,914,000 | $368,951,000 | $356,650,000 | $343,186,000 | $320,641,000 | $279,671,000 | $304,797,000 | $278,496,000 |
| Custom Procedural Solutions | $209,333,000 | $200,033,000 | $193,717,000 | $190,194,000 | $193,942,000 | $203,196,000 | $187,359,000 | $180,332,000 |
| OEM | $204,955,000 | $199,990,000 | $186,928,000 | $145,034,000 | $123,528,000 | $109,767,000 | $117,889,000 | $114,536,000 |
| Endoscopy Devices | $72,864,000 | $54,770,000 | $36,806,000 | $32,757,000 | $31,524,000 | $29,673,000 | $33,871,000 | $33,276,000 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cardiovascular Segment | $166,133,000 | $150,150,000 | $114,440,000 | $80,946,000 | $53,415,000 | -$7,042,000 | $25,780,000 | $49,289,000 |
| Endoscopy Segment | $18,587,000 | $5,543,000 | $9,504,000 | $6,617,000 | $7,501,000 | $5,480,000 | -$10,346,000 | $9,328,000 |
Operating Margin by Segment (%)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cardiovascular Segment | 11.5% | 11.5% | 9.4% | 7.2% | 5.1% | -0.8% | 2.7% | 5.8% |
| Endoscopy Segment | 25.5% | 10.1% | 25.8% | 20.2% | 23.8% | 18.5% | -30.5% | 28% |